infoholicresearchdwd7
Here are the Market Updates for ICT, Healthcare, Chemicals and Electronics & Semiconductors domain. Please add your faves to the list so I can discover more. And don't forget to vote for your faves!
Source: https://www.infoholicresearch.com/?utm_source=pravinmane&utm_campaign=LG
In North America, the presence of developed IT & healthcare infrastructure, promising government initiatives in the current healthcare infrastructure, and constantly improving reimbursement scenario would propel the neurostimulation devices market growth.
Breast cancer is the most common cancer among women and the second leading cause of cancer-related deaths in women after lung cancer. Advancements in screening and treatment for breast cancer have improved survival rates in the last few decades. Breast cancer is a kind of cancer formed in tissues of the breast. The most common types of breast cancer are ductal carcinoma, which begins in the lining of the milk ducts and lobular carcinoma, which starts in the lobules (milk glands) of the breast.
In the US, around 12% of women develop breast cancer over the course of their lifetime. In Canada, an estimated 26,900 women were expected to be diagnosed with breast cancer in 2019 and breast cancer accounts for nearly 25% of new cases of cancer among Canadian women.
North America was leading the global breast cancer drug market with more than 45% of the revenue in 2018. The presence of standard healthcare infrastructure, increasing awareness about early disease diagnosis, and the presence of established players are among the factors that make North America a major shareholder in the market.
Product approvals, collaboration, and development of new drugs are among the strategies followed by dominant companies to strengthen their position in the market. For instance, in May 2019, Novartis announced the US FDA approval for Piqray in combination with fulvestrant for the treatment of postmenopausal women and men with hormone receptor-positive, PIK3CA-mutated, human epidermal growth factor receptor-2 negative (HR /HER2-), advanced or metastatic breast cancer
Expiration of patents, high development cost of the drug, and strict regulatory guidelines are hampering the growth of the market. By considering all the above facts and figures and an in-depth analysis of the market, the market research company predicts that global breast cancer drugs market is going to reach revenue of around $36.7 billion, and is expected to grow at a CAGR of 9.4% during the forecast ed period of 2019- 2025.
Read the full report summary @ breast cancer drugs market
Download sample report @ breast cancer drugs market sample report.
Global breast cancer drugs market is expected to witness a CAGR of 9.4% during the forecast period to reach revenue of over $35.0 billion by 2025
Biogen released promising clinical trial data of its much-anticipated Alzheimer drug, aducanumab
This market research report includes a detailed segmentation of the global breast cancer drugs market by drug type (HER2 Inhibitors, Mitotic Inhibitors, Anti-metabolites, CDK4/6 Inhibitors, and Hormonal Receptors) and by regions (North America, Europe, Asia Pacific, Rest of the World). Read the full report summary @ breast cancer drugs market
According to the World Health Organization, proper collection, management, and use of information within healthcare systems will determine the system’s effectiveness in detecting health problems, defining priorities, identifying innovative solutions, and allocating resources to improve health outcomes.
Hospital Information System (HIS) achieves excellent quality scores in terms of administration services that include management of patient data, medication, and other documents. Also, Hospital Information System can assist medical officers and staff in avoiding common errors that certainly cannot be afforded in healthcare by tracking every single data needed. The best part of the HIS is that it can incorporate better revenue management with a customized hospital management software solution.
Electronic Health Record (EHR) software is another type of healthcare software that contains detailed information about patients. Typically, Electronic Health Record software contain data about a patient’s demographics, medical history, laboratory results, and allergies.
Cloud-based technology and Web-Based Medical Service (WBMS) such as eHealth, mHealth, and telehealth seem feasible with vast usage in the hospital industry. Private cloud service provides exceptional control over patient data that proves convenient to internal or outsourced hospital staff and increases its preference for escalating industry growth.
Most of the hospitals have the traditional infrastructure and are now focusing on the modernization of equipment. The growth of data produced by medical and clinical communities have huge requirements in advanced resources and techniques to store data.
The US and Canada have been successful in implementing electronic records in their healthcare system, and as a result, which would boost the overall market growth. Moreover, the presence of developed IT and healthcare infrastructure, promising government initiatives in executing a hospital information system in the current healthcare infrastructure, and constantly improving reimbursement scenario would further propel the market growth. The research report forecast that the Global Hospital Information System Market is expected to grow at a steady rate, i.e., 11.2% CAGR, during the forecast period 2019–2025.
Global Food Colorants Market By Type (Synthetic and Natural) By Applications (Dairy Food, Non-Dairy Food, Non-Alcoholic Beverages, Alcoholic-Beverages) and By Geography growing with CAGR of 5.2%
Global recycled plastics market is expected to grow at a CAGR of 6.8% during the forecast period to reach a value of $66.73 billion by 2025
Hospital information systems (HIS) are essential for managing processes in hospital departments. The report provides complete details about the usage and adoption rate of hospital information system products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market.
Global leukemia therapeutics market is expected to witness a CAGR of 6.2% during the forecast period to 2019-2025
Epoxy sealer will witness higher growth in #EuropeanMarket and will not be affected by #Brexit and market slowdown.
To know more...
Download sample report @ https://t.co/osXUnVYehB
Read the complete report summary @ https://t.co/ndzBxbkHes
The European epoxy sealer market is expected to grow at a CAGR of 4.6% during the forecast period to reach a value of $3.99 billion by 2025
The global computed tomography market is expected to witness a CAGR of 5.5% to reach revenue over $8.7 billion by 2025
Hospital Information System market is expected to grow at a CAGR of ~11.2% during the forecast period 2019–2025 to reach revenue of around $82.4 billion by 2025. Hospital information systems (HIS) are essential for managing processes in hospital departments. The report provides complete details about the usage and adoption rate of hospital information system products. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market.
Medical Tourism Market is expected to witness a CAGR of 16.1% to reach revenue of USD 112.1 Billion by 2025.
Biostimulants Market By Application (Foliar, Soil, Seed), By Active Ingredients, By Crop, and By Geography - growing with CAGR of 11.6%
The global TNF alpha inhibitors market is anticipated to grow at a CAGR of 3.6% during the forecast period 2019�2025.
Global Dental Market will grow at a CAGR of ~5.4% during the forecast period 2019–2025 #dentalimplants #dentalhealth #dentalindustry
Global Surgical Sutures Market will grow at a CAGR of 5.6% during the forecast period 2019–2025.
High Density Polymer Foam Market Revenue Is Expected To Rise Further to $74.02 Billion By 2023.
Did you know?
Specialists indicate that up to 5.5 million Americans aged 65 and above could have #Alzheimer disease.
The “Global Dialysis Market” is expected to witness a CAGR of 5.0% to reach $118.6 billion by 2025.
Global C-Arm will grow at a CAGR of 4.2% during the forecast period 2019–2025
Global Hemostats market is expected to witness a CAGR of 6.2% to reach revenue of $3.4 billion by 2025.
The global heart failure drugs market is expected to witness a CAGR of 9.1% to reach revenue of $19.9 billion by 2025.
